featured
Safety and Tolerability of Atezolizumab Plus Bevacizumab in Patients With HCC and Child–Pugh A and B Cirrhosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study
Hepatology 2022 Oct 01;76(4)1000-1012, A D'Alessio, CAM Fulgenzi, N Nishida, M Schönlein, J von Felden, K Schulze, H Wege, VE Gaillard, A Saeed, B Wietharn, H Hildebrand, L Wu, C Ang, TU Marron, A Weinmann, PR Galle, D Bettinger, B Bengsch, A Vogel, L Balcar, B Scheiner, PC Lee, YH Huang, S Amara, M Muzaffar, AR Naqash, A Cammarota, N Personeni, T Pressiani, R Sharma, M Pinter, A Cortellini, M Kudo, L Rimassa, DJ PinatoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.